Evidence map›Paper›PMID 25440054›Full record

ArticleCell metabolism2014

Specialized metabolites from the microbiome in health and disease.

Gil Sharon, Neha Garg, Justine Debelius, Rob Knight, Pieter C Dorrestein, Sarkis K Mazmanian

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06968299 (Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological Outcomes), which is not on this map. Cited by 311 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
311citing papers in PubMed, 3 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06968299 narecruitingnot on this mapstarted 2025, after this paper: background citation

Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological Outcomes: An Open-label Trial

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2025 to 2025Enrolled50ConditionsCognitive Functions Perceptual Disturbances, Cognitive Function Abnormal, Sleep, PsychologicalArmsExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
3 · Its place in the literature

Who cites it

311 citing papers in PubMed, 3 syntheses or guidelines pooled it, 564 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Bacterial-derived cyclic lipopeptides suppress dauer arrest inbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. A Functional Metabolomics Framework to Track Microbiome Drug Metabolism.bioRxiv : the preprint server for biology · 2026
    Article
  14. Article
  15. The gut-brain axis: mechanisms linking intestinal dysbiosis with stroke.Frontiers in cell and developmental biology · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

251 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Gil SharonDivision of Biology and Biological Engineering, California institute of Technology, Pasadena, CA 91125, USA.
Neha GargSkaggs School of Pharmacy & Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA 92093, USA.
Justine DebeliusDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA.
Rob KnightDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA; Howard Hughes Medical Institute, Boulder, CO 80309, USA.
Pieter C DorresteinSkaggs School of Pharmacy & Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA 92093, USA; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA.
Sarkis K MazmanianDivision of Biology and Biological Engineering, California institute of Technology, Pasadena, CA 91125, USA. Electronic address: sarkis@caltech.edu.
California Institute of Technology · USUniversity of Colorado Boulder · USUniversity of California, San Diego · USUniversity of Montana · US

Funding

San Diego Clinical and Translational Research InstituteUL1TR000100 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2012 to 2015
$19.7M
Protection from Mucosal Pathology by Gut Microflora during Experimental ColitisR01DK078938 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2009 to 2020
$5.1M
Investigating the Gut Microbiome for Novel Therapies and Diagnostics for AutismR01MH100556 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2013 to 2017
$2.8M
The chemical and genetic basis of interspecies interactionsR01AI095125 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, POGLIANO, KIT J · 2011 to 2014
$2.4M
Ecology of Cystic Fibrosis: Administrative SupplementR01GM095384 · NIGMS · SAN DIEGO STATE UNIVERSITY · PI ROHWER, FOREST L · 2011 to 2014
$1.9M
Molecular Mechanisms that Shape Gut Microbial CommunitiesR01GM099535 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2012 to 2015
$1.6M
The Gut Microbiome in Neurodegenerative DiseaseR01NS085910 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2013 to 2016
$1.3M
Protection from Mucosal Pathology by Gut Microbiota During Experimentas ColitisR56DK078938 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2016 to 2016
$618k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000100NCATS NIH HHS UL1TR000100NIAID NIH HHS AI095125NIAID NIH HHS R01 AI095125NIDDK NIH HHS DK078938NIDDK NIH HHS R01 DK078938NIDDK NIH HHS R56 DK078938NIGMS NIH HHS GM095384NIGMS NIH HHS GM099535NIGMS NIH HHS R01 GM095384NIGMS NIH HHS R01 GM099535NIMH NIH HHS MH100556NIMH NIH HHS R01 MH100556NINDS NIH HHS R01 NS085910
6 · The paper itself

Abstract

The microbiota, and the genes that comprise its microbiome, play key roles in human health. Host-microbe interactions affect immunity, metabolism, development, and behavior, and dysbiosis of gut bacteria contributes to disease. Despite advances in correlating changes in the microbiota with various conditions, specific mechanisms of host-microbiota signaling remain largely elusive. We discuss the synthesis of microbial metabolites, their absorption, and potential physiological effects on the host. We propose that the effects of specialized metabolites may explain present knowledge gaps in linking the gut microbiota to biological host mechanisms during initial colonization, and in health and disease.

Indexed as

MicrobiotaBacteriaCardiovascular DiseasesCystic FibrosisGastrointestinal TractHealthHumansMetagenomeNeoplasms

Identifiers

PMID25440054
PMCPMC4337795
OpenAlexW2092725930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.